Review Article

Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis

Figure 13

(a) Comparison of adverse events between iguratimod and placebo groups. (b) Comparison of adverse events between iguratimod and other DMARDs (MTX and SASP) groups.
310628.fig.0013a
(a)
310628.fig.0013b
(b)